Melphalan
Melphalan is a chemotherapeutic agent used in the treatment of a variety of cancers, including melanoma[1] and multiple myeloma.[2]
Melphalan Media
Syntheses: U.S. Patent 3,032,584; U.S. Patent 3,032,585 (both 1962 to NRDC).
References
- ↑ "Percutaneous hepatic perfusion with melphalan improved hepatic PFS in ocular, cutaneous melanoma | Hematology Oncology". Hemonctoday.com. Retrieved 2014-06-24.
- ↑ Cunningham, D.; Paz-Ares, L.; Gore, M. E.; Malpas, J.; Hickish, T.; Nicolson, M.; Meldrum, M.; Viner, C.; Milan, S.; Selby, P. J. (2014-06-20). "High-dose melphalan for multiple myeloma: long-term follow-up data". Journal of Clinical Oncology. Jco.ascopubs.org. 12 (4): 764–768. doi:10.1200/JCO.1994.12.4.764. PMID 8151320. Retrieved 2014-06-24.
